跳至主要内容
临床试验/NCT06185777
NCT06185777招募中不适用

Multi-professional Care Pathway and Network for the Promotion of Needs-oriented, Resident-oriented Exercise Therapy for Oncological Patients

University Hospital Heidelberg14 个研究点 分布在 1 个国家目标入组 2,500 人开始时间: 2023年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
2,500
试验地点
14
主要终点
Change from baseline to week 12 in physical function measured by the EORTC QLQ-C30

研究概览

简要总结

MOVE-ONKO is developing and implementing a guideline-based, multi-professional care pathway for the promotion and therapy of exercise for cancer patients. This pathway intended to serve as an interface between oncological care and existing or developing exercise therapy services in the local area of the participating hospitals. Needs- and side-effect-oriented care pathways are intended to give as many patients as possible access to quality-assured exercise therapy services close to home and thus to the supportive potential of exercise. The new care pathway will be develop in year 1 (phase 1) and will be established at 7 Comprehensive Cancer Centers (CCCs) in 3 model regions Heidelberg-Frankfurt-Mainz, Dresden-Berlin and Freiburg-Tübingen (phase 2) in Germany, as well as adapted accordingly in organ cancer centers and with established oncological care providers (phase 3 - Outreach). The aim is to ensure that exercise promotion and therapy can be integrated into standard care as comprehensively and sustainably as possible.

The implementation project will be evaluated according to the achievement of implementation and intervention goals. The implementation goals are utilization (reach) and actual implementation. Factors for successful implementation will be identified and incorporated into the procedure in phase 3 (outreach). Intervention goals are mapped at provider and patient level in both phases. They include improving physical functioning, increasing physical activity behavior, improving exercise-related health literacy, increasing motivation to exercise and increasing patient participation. For this purpose, patients with a cancer disease undergoing acute therapy aged 18 and over who are cared for in participating centers are surveyed four times over a period of 24 weeks using standardized questionnaires (baseline (t0) before the intervention, follow-up after 4 (t1), 12 (t2) and 24 (t3) weeks). In addition, the participating managers and service providers of the centers in phase 2 (implementation phase) and phase 3 (outreach phase) will be surveyed using standardized questionnaires and in-depth interviews. The longitudinal evaluation design enables an analysis of the changes in care structures and processes, the success of implementation and the experiences and outcomes of patients

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Change from baseline to week 12 in physical function measured by the EORTC QLQ-C30

时间窗: baseline till week 12 (& 12 week follow up)

Physical Function will be assessed within the validated 30-item self-assessment questionnaire of the European Organisation for Research and Treatment of Cancer (EORTC QLQ-C30, version 3.0). It comprises five multi-item functional scales (physical, role, emotional, cognitive, and social function), three multi-item symptom scales (fatigue, pain, nausea/vomiting), and six single items assessing further symptoms (dyspnea, insomnia, appetite loss, constipation, diarrhea) and financial difficulties. Scores range from 0 to 100. A higher score for the functional scales and global health status denote a better level of functioning, whereas a high score for symptom/single-item scale indicate a higher level of symptomatology/problems. Change = (Week 12 Score - Baseline Score)

次要结局

  • Change from baseline to week 12 in physical activity measured by the Godin-Shephard Leisure Time Physical Activity Questionnaire(baseline till week 12 (& 12 week follow up))
  • Change from baseline to week 12 in social support(baseline till week 12 (& 12 week follow up))
  • Reasons for discontinuing physical/exercise therapy at week 12 and follow-up(week 12 (& 12 week follow up))
  • Cancer Patients Information Needs at week 12 and follow-up(week 12 (& 12 week follow up))
  • Change from baseline to week 12 in patient activation(baseline till week 12 (& 12 week follow up))
  • Change from baseline to week 12 in physical activity-related health competence(baseline till week 12 (& 12 week follow up))
  • Patients' Experiences Across Health Care Sectors at week 12(week 12)
  • Patients' Shared Decision-Making experience at week 12(week 12)
  • Qualitative interviews and quantitative assessments with the RE-AIM framework to assess quality of pathway structure, processes and efficacy(baseline till week 12 (& 12 week follow up))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joachim Wiskemann

Prof. Dr. Joachim Wiskemann

University Hospital Heidelberg

研究点 (14)

Loading locations...

相似试验

Multi-professional Care Pathway and Network for the... | 临床试验